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We attempted transplantation of adult neural stem cells (ANSCs) inside an autologous venous graft following surgical transsection
of nervis cruralis with 30mm long gap in adult pig. The transplanted cell suspension was a primary culture of neurospheres from
adult pig subventricular zone (SVZ) which had been labeled in vitro with BrdU or lentivirally transferred ﬂuorescent protein.
Lesion-induced loss of leg extension on the thigh became deﬁnitive in controls but was reversed by 45–90 days after neurosphere-
ﬁlled vein grafting. Electromyography showed stimulodetection recovery in neurosphere-transplanted pigs but not in controls.
Postmortem immunohistochemistry revealed neurosphere-derived cells that survived inside the venous graft from 10 to 240 post-
lesion days and all displayed a neuronal phenotype. Newly formed neurons were distributed inside the venous graft along the
severed nerve longitudinal axis. Moreover, ANSC transplantation increased CNPase expression, indicating activation of intrinsic
Schwann cells. Thus ANSC transplantation inside an autologous venous graft provides an eﬃcient repair strategy.
1.Introduction
Nerve injuries which are frequent in civil practice [1, 2]a n d
catastrophe-like earthquake [3, 4]o rt s u n a m i[ 5] combine
associative lesion with crush syndrome. War improves the
risk of gap and of treatment delay with ballistic wounds [6]
because these ones are less prone to emergency than vascular
injuries[7].Thisriskpertainsafterwarwithremanentexplo-
sive[8].Thefunctionalpronosticisdependentonthetypeof
wound: transsection, crush, or gap, which has been further
categorized according to the length of the gap, the type of
nerve (sensitive, motor or mixed), localization, association
of injuries, and patient’s ageing, time of surgery, and vascular
environment [9–12].
Neuroguides and especially vein grafts are regularly used
to bridge small nerve gaps shorter than 3cm; for long nerve
gaps, autologous nerve graft has become the gold standard
since the second war [13, 14]. But nerve repair outcome
depends on fascicle concordance [15] and scar development,
so expected alternatives for long nerve gaps remain a chal-
lenge to improve recovery after this type of lesion. Surgical
trials to improve nerve repair have mainly targeted diversiﬁ-
cation of grafted neuroguides with resorbable materials [16].
The outcome has been improved by neuroguide preloading
with extracellular matrix components [17–19], growth fac-
tors[20],orculturedregeneration-enhancingcells.Thelatter
strategy, or cell therapy, has been attempted with primary
cultures of Schwann cells [21, 22], olfactory bulb enshealting
cells [23], or various types of stem cells [24]. In these studies,
progenies of grafted stem cells mostly proved to be glial cells,
which indirectly enhance axonal regeneration [24].
Neural stem cells from adult brain (ANSC) have been
scarcely assayed to help postlesional repair of peripheral
nerves, despite their strong potential of integration and2 Stem Cells International
development into neurons [25]. The present study is based
on the hypothesis that ANSC grafting inside a venous neuro-
guide might be eﬃcient to bridge a long nerve gap in adult.
We tested this hypothesis in the pig, which is the non-pri-
mate animal species most closely related to human and is
prone to surgery and anesthesia conditions very close to
human protocols in clinic [26]. To this aim, we have char-
acterized primary cultures of neural stem cells from adult pig
brain,byoptimizingtheneurosphereassayonsubventricular
zone explants [27]. In the present study, we labeled such
primary expanded ANSC in vitro with either BrdU or len-
tiviralgreenﬂuorescentproteingenetransfer,andwegrafted
labeled neurospheres into an autologous venous bridge after
a surgical 30mm long gap in adult pig nervi cruralis.W e
compared neurosphere-grafted and control pigs for func-
tional recovery and assessed the fate of grafted cells inside
the lesioned nerve at various post-lesion intervals.
2.MaterialandMethods
2.1. Animals. Twenty-four adults, 4-month-old Large White
Landrace pigs were used in the present study. They were
housed with ad libitum access to water and standard food
pellets, in lodges that comprised one yard and one hard
infrared-heated shelter. All in vivo experimental protocols
were approved by the local Ethics Committee on the protec-
tion of animals used for scientiﬁc activities with the proto-
col number 31/2006/IMTSSA/UCPE. Personal protocol nu-
mber for surgery and experimentation with pigs was 2007/
29/DEF/DCSSA (to O. Liard). All eﬀorts were made to min-
imize the number of animals used and their suﬀering.
2.2. Anesthesia. Deep anesthesia was initiated by intramus-
cular premedication with 30mg/kg ketamine (Imalgene
1000, Merial, Lyon, France), 0.1mL/kg acepromazine (Vet–
r a n q u i l ,C a l m i v e t ,B a y e r ,P u t e a u x ,F r a n c e ) ,a n d2 5 μg/kg
atropine sulphate (Meram, Melun, France). The animal was
then equipped with a peripheral intravenous perfusion de-
livering Ringer-lactate-5% glucose serum at 5–7mL/kg/h,
with adhesive electrocardiographic electrodes in CM5-SpO2
(ECG monitor S5, Datex Ohmeda, Madison, WI, USA), and
with an artiﬁcial oxygenator. Anesthesia induction was per-
formed by intravenous injections of 2mg/kg propofol (Di-
privan, Bayer) during 30sec slowly, and of sufentanil (Su-
fenta, Bayer) three times at 1.5μg/kg. Local glottis anesthesia
was made with 5% lidoca¨ ıne spray (Xylocaine, Bayer), be-
fore orotracheal intubation with a monolight cannula (in-
ternal diameter 6.5mm). Ventilation of lung parenchyma
was checked with a stethoscope and mechanically assisted.
General anesthesia was sustained with electrically driven in-
travenous infusion of propofol 2mg/kg/h (Diprivan, DCI),
sufentanil 1μg/kg/h (Sufenta, DCI) and rocuronium bro-
mide 0.15mg/kg/h (Esmeron, DCI); curarisation was super-
vised by means of a S5 monitor (Entropie module) but was
not released for EMG. Antibioprophylaxy was administered.
All along surgery, the cardioventilatory parameters (heart
and ventilation rates, electrocardiogram, blood oxygena-
tion, ventilation pressure and volume, MAC, temperature,
hemoglucotest) as well as the sleep threshold were constantly
watched with the S5 monitor.
2.3. Brain Tissue Sampling for Primary Neural Stem Cell Cul-
ture from Adult Pig. Separate animals were dedicated for pri-
mary culture and in vitro expansion of neural stem cells
from brain subventricular zone (SVZ) as previously de-
scribed [27]. On each deeply anesthetized pig, the dorsal face
of the skull was cut with an electric saw and removed. A
15mm thick coronal slice of the brain was performed with
a scalpel at the commissural level of midbrain, manually ex-
planted and transferred at 4◦C on ice bed-laid sterile metal
plate, beside a Bunsen ﬂame for atmosphere sterilization.
The experimental animal was thus alive until the explan-
tation of the brain tissue slice. Each pig was sacriﬁced
immediately after brain tissue sampling by intravenous
injection of Dolethal (R) pentobarbital (DCI) at 1.5mL/kg.
2.4. Primary Culture of SVZ Neural Stem Cells (“Neurosphere
Assay”). As previously described [27], SVZ pieces were
quickly microdissected from the thick midbrain slice (above)
along the ventrolateral ﬂoor of lateral brain ventricles in low-
calcium artiﬁcial cerebrospinal ﬂuid (aCSF: 124mM NaCl,
5mM KCl, 3.2mM MgCl2,0 . 1m MC a C l 2,2 6m MN a H C O 3,
100mM glucose, and pH 7.38). Tissue samples were rinsed
twice with aCSF and digested ﬁrst in 40U cystein-EDTA-
β-mercaptoethanol-preactivated papain (Sigma, L’Isle
D’Abeau, France) for 10min at 37◦C, then in 250μL undi-
luted TrypLE Express solution (heat-resistant, microbially
produced, puriﬁed trypsinlike enzyme, Gibco # 12604-013,
Invitrogen,Cergy-Pontoise,France)for10minat37◦C.After
the addition of 750μL of fresh aCSF and centrifugation for
8min at 400g at room temperature, the cell pellet was resus-
pended in 1mL culture medium (DMEM (Sigma), 1x B27
(Gibco Invitrogen), 200U/mL penicillin, and 200μg/mL
streptomycin (Gibco Invitrogen)) containing 20ng/mL Epi-
dermal Growth Factor (EGF, Gibco Invitrogen) and 20ng/
mL basic Fibroblast Growth Factor (bFGF, Gibco Invitro-
gen). The cells were dissociated gently with a 26G steel
needleonasteriledisposable1mLsyringe,countedonaMa-
lassez slide, and seeded at 20,000 cells per mL in 6-well plates
(Falcon,BDBiosciences,Bedford,USA).Culturesweremon-
itoreddailytofollowthemorphologicalgrowthoftheneuro-
spheres; passage was performed when the majority of
spheres were 100–120μm in diameter. For passage, the pri-
mary spheres were collected in sterile tubes, incubated for
45–60min at 37◦Ci n2 5 0 μL undiluted TrypLE Express
solution (Gibco Invitrogen) per 6mL culture-derived pellet,
and dissociated gently with a 26G steel needle on a 1mL
sterile syringe; dispersed cells were centrifuged, counted,
and seeded as above. All culture media were renewed by the
replacement of 2mL of medium per 4mL well every 2-3-
days. For immunocytochemistry, coverslips bearing diﬀer-
entiated spheres were rinsed in PBS, ﬁxed in 4% parafor-
maldehyde-containing PBS for 20min at 4◦C, and kept in
PBS at 4◦C until the assay.
2.5. In Vitro Labelling of Neurosphere Cells. In the ﬁrst set
of experiments, tertiary neurospheres were incubated withStem Cells International 3
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Figure 1: LV-GFP-labeled secondary neurosphere from adult pig SVZ, just before transplantation and 3 days after in vitro infection with the
lentiviral vector of GFP, as observed under a photonic microscope with natural light (a) or GFP ﬂuorescence (b). Scale bars: 50μm.
the DNA synthesis precursor bromo-2-deoxy-uridine at
30μM (BrdU, Sigma) from 2 DIV after passage up to 8–10
DIV, BrdU being added fresh daily from concentrated stock.
In a second set of experiments, lineage labelling was per-
formed by infection of secondary neurospheres with a lenti-
viral vector of green ﬂuorescent protein gene (LV-GFP) at 4-
5DIVafterpassage.LV-GFPwasfreshlysynthetized,titrated,
and tested as previously described [28], stored at −80◦Ca n d
unfrozenjustbeforeuse.Neurospherecultureswerepreincu-
bated30mininthepresenceof1mMpolybrene(Sigma)and
void lentiviral particles (VLP, 29) at 0.1x M.O.I., and further
incubated 2h with fresh culture medium containing 1mM
polybrene and LV-GFP at 0.3x M.O.I.; incubation medium
was then replaced by fresh standard culture medium. LV-
G F P - i n f e c t e dn e u r o s p h e r e sw e r ea l l o w e d3d a y sc u l t u r ei n
standard conditions for optimal lineage labelling (Figure 1);
[28].
After optimal culture period (5-6 days for BrdU, 3 days
for LV-GFP) and just before transplantation on the nerve
lesion site (see below), neurospheres were collected, centri-
fuged 4min at 800g, and resuspended in fresh culture medi-
um at 3 × 103 spheres per mL.
2.6. Postlesional Grafting Surgery. The surgical approach was
realized on the median face of thigh to isolate nervis cruralis.
Nerve damage was established in the right N. cruralis by
creating a 30mm gap, which was then bridged with an autol-
ogous vein segment sampled from v. mammelian externalis.
This venous neuroguide was sutured at both ends over the
perinevre of the sectioned nerve. In some animals, once the
venous shaft was sutured at the proximal end of the lesioned
nerve, 300μL of freshly prepared neurosphere suspension
(103 spheres) were gently infused with a micropipet into the
oppositeendoftheneuroguide,whichwasthensuturedonto
the distal lesioned nerve end. In other animals (controls),
the venous neuroguide was sutured without any additional
manipulation.
In the ﬁrst set of experiments, lesioned pigs were thus
grafted with autologous vein shafts which were either emp-
ty (controls, N = 2) or ﬁlled with BrdU-prelabeled
neurospheres (N = 4). These animals were allowed 8 or 45
days survival after lesion.
Inthesecondsetofexperiments,lesionedpigsweregraft-
ed with venous neuroguides which were either empty (con-
trols, N = 3) or ﬁlled with LV-GFP-labeled neurospheres
(N = 6). These animals were allowed 8 months survival after
lesion.
2.7. Functional Analysis of Lesioned Animals. Animal be-
haviour was evaluated by assessing muscular atrophy, deﬁcit
of leg extension over the thigh. Each animal was examined
before peripheral nerve lesioning and at days 45, 90, 180, and
240 following surgical bridging.
Motor function of the crural nerve was assayed by elec-
tromyography, using pregeled surface electrodes connected
to a portable electromyographic recorder (Keypoint (R)
v6.01, Medtronics, MN, USA). Bipolar concentric needles
(diameter 0.47mm) were applied on muscle quadriceps fem-
ori for stimulodetection analyses along N. cruralis.S t i m u l i
were single 100mA shocks, ranging from 0.1 to 1msec dura-
tions. Electromyography was performed on animals before
andat45,90,180,and240daysaftertransection.Valueswere
recorded in terms of voltage, amplitude and time latency of
detectable electromyographic activities.
2.8. Immunohistochemistry. At the end of postlesional sur-
vival, the operated region of N. cruralis of each experimental
pig was dissected out of the thigh under anesthesia and
ﬁxed by immersion in a 4% paraformaldehyde solution in
0.05M, pH 7.4, NaH2PO4/Na2HPO4 buﬀer for 24h at 4◦C,
then rinsed for 24h at 4◦C in 0.1M, pH 7.4 phosphate-
buﬀered saline (PBS). It was then cryoprotected for 72h in
a 30% sucrose solution, ﬂat-embedded in OCT mounting
medium and snap-frozen in liquid isopentane at −40◦Cf o r
storage at −80◦C. Longitudinal 20μm-thick sections were
made in a cryostat (Leica 2800), mounted on commercial
precoated slides (Superfrost-Plus, Fisher-Scientiﬁc, Canada),
dried overnight at ambient air, and stored at −20◦C.
For immunohistoﬂuorescent labellings, these tissue sec-
tions were brought back to room temperature and perme-
abilized in 0.1MPBS with 0.5% Triton-X-100. For nuclear4 Stem Cells International
Table 1: List of primary antibodies used.
Antigen Antibody Supplier Cell-type speciﬁcity Dilution
BrdU Rat polyclonal ImmunologicalDirect.com none 1/100
CNPase Mouse monoclonal Sigma, L’Isle-d’Abeau, France; C-5922, clone 11-5b Schwann cells 1/200
GFAP Rabbit polyclonal Dako, Trappes, France; Z0334 Astrocytes, neural stem cells 1/1000
NeuN Mouse monoclonal Chemicon, MAB377 Mature neurons 1/100
NF-68 Mouse monoclonal BD-Biosciences, Heidelberg, Germany Mature neurons 1/400
S100β Rabbit polyclonal Dako, Trappes, France Astrocytes, Schwann cells 1/500
antigens, tissue sections were also treated 15min in 10mM
sodium citrate solution (pH 5.5) at 95◦C. After a PBS
rinse, all preparations were incubated in blocking buﬀer
(0.1MPBS, 0.1% Triton, 3% bovine serum albumin, 5%
normal serum) for 1h, then overnight at 4◦C with one pri-
maryantibody(Table 1).Afterthree5-minute-rinses infresh
0.1MPBS, immunohistochemical labelings were revealed by
2h incubation at room temperature in the dark with the ap-
propriate Alexa-594-conjugated secondary antibodies (Mo-
lecular Probes, Eugene, OR, USA; 1/400). For double-stain-
ing experiments, Alexa-594-revealed slides were rinsed three
times in fresh 0.1MPBS and further incubated overnight at
4◦C with another primary antibody, which was revealed with
appropriate Alexa-488-conjugated secondary antibody (Mo-
lecular Probes; 1/200). After rinsing, ﬂuorescent staining of
cell nuclei was performed by 5min incubation in the dark-
with DAPI (0.5μg/mL, Sigma). Labeled slides were cover-
slipped with aqueous mounting medium (Vectashield, Vec-
tor, Abcys, France) and photographed with a ﬂuorescence
microscope. CNPase immunohistochemical labeling was
quantiﬁed on these photomicrographs by using the ImageJ
software.
3. Results
3.1.ClinicalResults. Beforesurgery,allexperimentalanimals
were healthy and displayed no walking deﬁcit. After surgery,
noneofoperatedanimalsdisplayedanyscarinfectionorhost
rejection response.
By clinical observation, loss of the right leg extension
over the thigh was systematically observed after the surgical
nerve transsection. This motor defect was maintained up to
240 days in animals which had crural nerve gap repaired by
empty autologous venous bridge only. By contrast, lesioned
leg extension over the thigh reappeared between 90 and 180
days in animals which had crural nerve gap repaired by the
same type of autologous vein trunk ﬁlled with exogenous
neurospheres.
3.2. Electromyography. Prior to surgery, electromyograms of
m. quadriceps vast internal displayed amplitudes of 4.9 to
6.1mVandpoststimuluslatenciesof0.89to3.7ms.Immedi-
ately after surgical realization of N. cruralis substance loss,
electromyograms of m. quadriceps were negative for all
experimental animals, whatever their venous bridge had
been ﬁlled or not with neurosphere suspension.
At 180 days (25 weeks) after lesion, neurosphere-trans-
planted pigs displayed positive electromyograms of m.
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Figure 2: Electromyographic evaluation of muscle quadriceps
femoriat90,180,and240daysfollowingN.cruralislesionandgraft
of GFP-labeled neurospheres inside a venous bridge before (“before
surg.”) or after (“D + 90”, “D + 180”, “D + 240”) surgery.
quadriceps with 0.6 to 0.9mV amplitudes and 0.96 to
2ms latencies, whereas electromyograms of control animals
remained negative (Figure 2).
At 240 days (34 weeks) after lesion, m. quadriceps
electromyograms of neurosphere-transplanted pigs were
improved up to 2.8–3.1mV amplitudes with 2.4–2.5msStem Cells International 5
(a) (b)
(c)
Figure 3: Localization of transplanted BrdU-labeled neurospheres in the bridged nerve at 8 days after lesion, by postmortem
immunohistochemistry. BrdU immunoreactivity is revealed by red Alexa-594 ﬂuorescence on longitudinal postﬁxed graft sections at low
(a) and high (b, c) magniﬁcations. Enlarged ﬁelds (b, c) are localized as white forms in (a). Transplanted neurosphere cells are found either
sparsed (b) or clustered (c) inside the venous bridge. Scale bars: 0.5mm (a), 100μm( b ,c ) .
(a) (b)
Figure 4: Double BrdU-DCX immunohistochemistry on a sagittal section from a neurosphere-grafted bridged nerve at 8 days after
lesion. One given ﬁeld was sequentially photographed with ﬂuorescent wavelengths revealing, respectively, Alexa-594-labeled BrdU
immunoreactivity (a) and Alexa-488-DCX one (b). Note the extensive nuclear colocalization of the immature neuron marker DCX with
BrdU (b). Scale bars 100mm.
latencies, while electromyograms of controls were still neg-
ative (Figure 2).
3.3. In Situ Fate of Grafted Pig Neurosphere Cells. In the ﬁrst
experiment, grafted neurosphere cells had been labeled by
in vitro BrdU incorporation prior to graft. By immunohis-
tochemistry on postmortem venous grafts, groups of BrdU-
immunoreactive cells were detected inside the venous tube
(Figure 3). In grafts sampled at 8 days after surgery, most
of these BrdU+ cells were clustered in sphere-like assemblies
(Figures 3(a) and 3(c)) while some were sparsed inside the
venous tube (Figure 3(b)). Most of BrdU+ cells were also
immunoreactive for doublecortin (DCX) which is a speciﬁc
marker of immature neurons (Figure 4). At 90 days after
surgery, BrdU+ cells were still observed inside the venous
tube and displayed immunoreactivity for NeuN, that is, a
marker of diﬀerentiated neurons (Figure 5).
In the second experiment, expanded secondary neuro-
spheres at 8 DIV had been stained by LV-GFP transfection
just before collection and postlesional transplantation on6 Stem Cells International
(a) (b)
Figure 5: Double BrdU-NeuN immunohistochemistry on a sagittal section from a neurosphere-grafted bridged nerve at 90 days after
lesion. One given ﬁeld was sequentially photographed with ﬂuorescent wavelengths revealing, respectively, Alexa-594-labeled BrdU
immunoreactivity (a) and Alexa-488-NeuN one (b). Note the extensive nuclear colocalization of the mature neuron marker NeuN with
BrdU (b). Scale bars 100mm.
(a) (b)
(c) (d)
Figure 6: GFP lineage-labelling detection in DAPI-counterstained sagittal sections of venous bridges with (a, b) or without (c, d)
transplantation of LV-GFP-labeled neurospheres, at 240 days after lesion. GFP-expressing neurosphere progeny (a, c) and DAPI-labeled
tissue cell nuclei (b, d) are detected by ﬂuorescence microscopy by using, respectively, adequate wavelengths. Scale bars: 0.5mm (a, b),
100μm (c, d).
the pig nerve gap. All neurospheres displayed ﬂuorescent
GFP labeling in most, but not all, cells (Figure 1). At either
45, 90, 180, or 240 days after lesion, sphere transplantation,
each vein-bridged and LV-GFP sphere-transplanted nerve
segment displayed a number of GFP-ﬂuorescent cells which
were exclusively localized inside the nerve fascicles (Figures
6(a)and6(b))andabsentinnontransplantedcontrolbridges
(Figures 6(c) and 6(d)). Combined immunohistoﬂuorescent
labeling of either NeuN or neuroﬁlament NF-68 revealed
that most of GFP ﬂuorescence was colocalized with these
neuronal markers (Figures 7(a)–7(c)). By contrast, GFP ﬂu-
orescence did not colocalize with either of the glial markers
assessed: S-100b (Figures 7(d)–7(f)), GFAP, CNPase.
Interestingly, at 180 and 240 days after nerve lesion
and GFP-expressing neurosphere transplantation, CNPase
immunohistoﬂuorescent labeling was much higher than
in vein-bridged lesioned controls which had not received
neurosphere transplantation (Figure 8). Both the number ofStem Cells International 7
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Figure 7: GFP detection and phenotypic marker immunohistoﬂuorescence (NeuN on left column, Schwann cells’ CNPase on right column)
in sagittal sections of venous bridges which had been transplanted with LV-GFP-labeled neurospheres and were sampled at 240 days after
lesion. (a, d) green endogenous ﬂuorescence for detection of lineage-infected neurosphere progeny; (b, e) Alexa-594-revealed phenotypic
marker immunoreactivities; (c, f) merged ﬂuorescences. Note yellow-labeled colocalization of GFP-expressing neurosphere progeny with
NeuN immunoreactivity (c) but not with CNPase (f). Scale bars: 0.5mm.
CNPase-immunoreactive Schwann cell processes and their
labeling intensities were higher in neurosphere-grafted
nerves thanincontrols.Bydensitometric quantiﬁcationwith
the ImageJ software, immunohistochemical CNPase labeling
of neurosphere-grafted lesioned nerves, at 240 days after
lesion, reached 276 ± 2% of the 100 ± 2.9% value of lesioned
controls which were devoid of neurospheres; this diﬀerence
being statistically signiﬁcant at P<0.001 by Anova.
4. Discussion
Degeneration of the distal axon segment is the consequence
ofaxotomyandthechallengeofnerverepairistoconnectthe
proximal stump to this distal segment. For long nerve gap, it
is a race between axon regeneration and distal degeneration
with phenotypic change of Schwann cells [24]. Autologous
nervegraftisthegoldstandardbutresultsarenotsatisfactory
[15]. Any alternative is currently believed to require a neu-
roguide, providing a permissive microenvironment to in-
crease axonal regeneration and to preserve supportive cells
anddistalaxons.Stemcellshavealreadybeenstudiedbutdif-
ferentiationwasmostlytowardssupportivecells.Neuralstem
cells have been reported to become integrated and provide
new neurons after transplantation within central nervous
system with permissive microenvironment [25]. In order to
test the eﬃciency of this type of graft for postlesional repair8 Stem Cells International
(a) (c)
(b) (d)
Figure 8: CNPase immunohistoﬂuorescence on sagittal sections of venous bridges without (a, b) or with (c, d) transplantation of LV-GFP-
labeled neurospheres, which had been sampled 240 days after lesion. Alexa-594 ﬂuorescence-revealed CNPase immunoreactivity (a, c) is
combined with histoﬂuroescent DAPI counterstaining (b, d). Note that Schwann cell labelling density is strikingly higher in neurosphere-
transplanted graft (c, d) than in void venous bridge (a, b). Σχαλεβαρσ: 100μm.
of peripheral nerves, we have established a primary culture
of adult pig neural stem cells which generate neurons in vitro
in our previous report [27]. In the present study, we show
for the ﬁrst time in adult pig that transplantation of in vitro
preexpanded adult neural stem cells into a peripheral nerve
gap inside a venous bridge both leads to genesis of longitudi-
nally aligned neurons and improves functional recovery.
4.1. Methodological Considerations. The present experimen-
tal protocol of nerve lesion: transsection and 30mm long
nervesubstanceremoval,hasbeenchosentomimicthecom-
mon cases of long nerve injury in human clinics. In these
cases indeed, whatever be the initial type of injury (section,
tearing, crush), the surgical regularization of both nerve
stumps corresponds to a model of transsection.
Autologous vein segment graft as a nerve conduit has
been established as an eﬀective treatment for the repair of
nerve gaps less than 3cm [29, 30]; it is used in hand surgery
[31] and in pediatrics [32]. In a recent study [33], histomor-
phological examination of the sections proximal to, from,
and distal to the repair zone over three months revealed less
epineural scarring, a thinner epineurium, more regenerated
axons and fewer inﬂammatory cells in groups where vein
grafting was used, because the vein graft provided additional
mechanical and chemical support in the size discrepancy of
the nerve regeneration. A small vein graft keeps its property
for end-to-side neurorrhaphy [34], but size discrepancy
between the donor and recipient nerves and length of the
bypass are another problem with the risk of collapse. Vein
bridging also gives excellent results in secondary repair of
neglected injuries [35]. The present protocol is routinely re-
alized in adult pig, as a convenient training system for
human-operating surgeons.
The present postlesional cell therapy attempt used an in
vitro expanded primary culture of adult pig brain neuro-
spheres which had been extensively characterized in a pre-
vious study [27]. We had indeed shown that the present pro-
tocols of adult pig subventricular zone sampling and neuro-
sphere assay allow to purify and maintain true neural stem
cells with unlimited proliferative potential, self-renewal ca-
pacity, and ability to generate all neural cell types [27]. In
particular, these neurospheres from adult pig SVZ displayed
the same proportions of neurons (25%), astrocytes (70%),
and oligodendrocytes (5%) as neurospheres from various
adult rodent brain structures [36–38].
The procedure for ﬂuorescent lineage labeling of grafted
neurospheres used a lentiviral vector of GFP which has been
validated previously [28]. Freshly prepared lentiviral parti-
cles were quantiﬁed by multiplicity of infection (MOI) de-
termination using routine virologist assays, for optimization
of the neurosphere labeling. We checked that this in vitro
procedure allowed extensive labeling of adult pig neuro-
spheres without alteration of their cell dynamics. It allowed
subsequent identiﬁcation of grafted cell progenies in situStem Cells International 9
merely by histoﬂuorescence, which easily enabled to perform
phenotype characterization by immunohistochemistry as
revealed with diﬀerent ﬂuorophores.
4.2. Functional Recovery Enhancement by Vein-Guided Neu-
rosphere Transplantation. Electromyographic evaluation of
the muscle which is innervated by the lesioned nerve dem-
onstrated that our protocol of venous-graft-assisted neuro-
sphere transplantation strongly improved functional recov-
ery at 6 months after lesion, as compared to controls. Our
subsequent histoﬂuorescent analyses provided putative cyto-
logical substrates for such positive inﬂuence of grafted
ANSC-derived cells.
In the same time, clinical evaluation was based on a
simple observation. The section of the crural nerve pulled a
deﬁcientﬂexionofthethighonthepond.Theonlyrecoveries
of normal step were observed on the transplanted animals.
Themainquestionwastoknowifthisrecoverywasboundto
accelerated axonal regrowth or to the creation of a functional
intermediate neuronal bypass. In fact we have a double
observationofneuronsandregrowthoftheaxonsofthehost.
4.3. Neuronal Outcome of Grafted Neurospheres inside the
Venous Bridge. In the present cell therapy attempt, the graft-
ed neurospheres yielded exclusively neuronal progenies
whatever be the postlesional delay. This outcome is striking
since the neuronal yields from adult SVZ neural stem cells
are known to reach only 25% neurons in vitro and 75% in
the olfactory pathway in vivo [25, 37, 39]. The present in vivo
result indicates that the venous graft provided an eﬃcient
proneurogenic environment for the transplanted neuro-
spheres. It is in keeping with the recent demonstrations
that vascular walls favor neurogenesis from adult neural
stem cells [38, 40, 41], which is mediated in some rodent
models by the vascular endothelium-derived growth factor
(VEGF) [42]. Our results suggest that choosing a venous
trunk versus an artiﬁcial neuroguide to bridge a nerve
gap is an interesting solution because of intrinsic property.
Furthermore, all surgeons are able to take a vein trunk on
superﬁcial vein network and this is much less expensive than
neurotubes in emergency conditions. At the same time, to
understand mechanism of interaction between endothelial
cells and grafted neural stem cells will allow progress for the
development of new artiﬁcial neurotubes. More generally,
local tissue microenvironment has been formally demon-
strated to be determinant on the phenotypic fate of stem-
cell-derived progenies: for instance, nonneurogenic neural
stem cells from the adult spinal cord generated neurons
exclusively, once transplanted into the hippocampus [43].
Thesenewlyformedneuronssurvivedatlongdelaysafter
the original transplantation, which indicates they have been
successfully integrated inside the severed nerve. Further, the
linear distribution of these neuronal perikarya, parallel to
the longitudinal axis of the lesioned nerve, suggests that the
new neurons might be interconnected into multisynaptic
netsbridgingthelesionalgapofpreexistingnerveﬁbers.This
multisynapticnetshavebeendescribedafterneuralstemcells
graft [44, 45] This interpretation is also supported by the
evolution of transplanted cell clusters across time inside the
venous graft, that is, from spherical assemblies in the ﬁrst
weekafterlesiontolinearchainlikesuccessionsofsparsecells
at longer delays. Such outcome arises apart of the strategies
for peripheral nerve repair which have been worked out thus
far and consist in stimulating either axonal regrowth into the
distal nerve end or remyelination with additional Schwann
cells [24].
The present results contrast with previous ones using
diﬀerent kinds of transplanted cells, like fœtal neural stem
cells, which triggered Schwann cell like proliferation in the
lesioned peripheral nerve [46], promoting in turn myelinisa-
tion and indirectly regeneration [47]. In addition, transplan-
tation of immortalized C17.2 cells from postnatal cerebel-
lum, which were shown to be distinct of neural stem cells
[48], has been reported to trigger tumor formation in a rat
model of injured sciatic nerve [49]. Adult neural stem cells
are especially relevant for cell therapy from this viewpoint,
because they were demonstrated to display exceptionally
high resistance to tumorigenesis and senescence [50].
4.4. Possibility to Graft New Neurons into a Peripheral Nerve
Gap. There are two approaches, either to transplant neuro-
ns, or to transplant stem cells possessing neuronal diﬀeren-
tiation potential. For primary neurons, dorsal root neurons
can be prepared in vitro and their axons stretch-growth [20].
Moreover, engineered nervous tissue construct consisted of
longitudinally aligned axonal tracts spanning two neuronal
populations, embedded in a collagen matrix and inserted in
aP G At u b e[ 44] demonstrated neuronal survival during 112
days after surgical repair of the sciatic nerve in the rat. But
only studies on the big animals allow the study of nerve gaps
in good conditions.
4.5. High Survival Rate of Allogenic Transplants. In our
study, adult neural stem cells were prepared in vitro after
explantation of SVZ cells from another pig, and allogenic
grafted cells were integrated without immunosuppressive
therapy. The same observation was noted for embryonic rat
progenitors for the adult rat sciatic nerve [44]a n dw i t h
xenograft of embryonic rat neural stem cells into a collagen
conduit for the rabbit facial nerve injury model [51]. In
these attempts, grafted cells were expanded in vitro before
transplantation, like in the present study.
4.6. Activation of Intrinsic Schwann Cells by Neurosphere
Transplantation. Phenotypic characterization of grafted cell
progenies showed that our transplanted neurospheres gener-
ated no Schwann cell directly, but they triggered increases of
the number and activity of this cell population as compared
tocontrols.CNPase+cellswereobservedalongaxonalregen-
eration but were always LV-GFP-. This result is in keeping
with a previous report showing that venous graft favored
Schwann cells proliferation after nerve lesion [52]. How-
ever, since in the present study controls have received a
neurosphere-devoid venous graft, our results indicated that
neurosphere cells emit diﬀusible signals that stimulate
Schwann cells. Neurospheres have indeed been shown in
vitro to secrete neurotrophic factors [53, 54].10 Stem Cells International
5. Conclusion
The positive impact of the present cell therapy protocol can
be attributed to genesis and integration of new neurons
inside the lesioned nerve and/or to indirect activation of
intrinsic Schwann cell population. However, Schwann cell
activation was previously shown to occur after grafting a
venous segment onto the lesioned nerve without neural stem
cells inside. Therefore, the speciﬁc beneﬁt of the present pro-
cedure is likely caused by the neurosphere transplantation,
and hence by the genesis of new neurons inside the lesioned
nerve. LV-GFP is conﬁrmed to provide an excellent marker
for grafted cells across long-time studies. Both new neuron
genesis and host Schwann cell proliferation contributed to
regenerate new axon fascicles in the host to bridge the long
nerve gap, and the functionality of this histological repair
was demonstrated in the same animals by electromyography
andclinics.Largeanimals,andespeciallythepig,allowrepair
and study of long nerve gap with clinical conditions close to
human. These results were obtained without adjunction of
extracellular matrix or extrinsic growth factor. The present
study thus provides a hope for improvement in human
clinics.
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